Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

15,360 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Development of an umbilical cord blood transplantation-specific nonrelapse mortality risk assessment score.
Okada Y, Usui Y, Hayashi H, Nishikubo M, Toubai T, Uchida N, Tanaka M, Onizuka M, Takahashi S, Doki N, Uehara Y, Maruyama Y, Ishiwata K, Kawakita T, Sawa M, Eto T, Ishimaru F, Kato K, Fukuda T, Atsuta Y, Kanda J, Yakushijin K, Nakasone H. Okada Y, et al. Among authors: tanaka m. Blood Adv. 2024 Mar 26;8(6):1359-1368. doi: 10.1182/bloodadvances.2023011837. Blood Adv. 2024. PMID: 38163321 Free PMC article.
Allogeneic hematopoietic stem cell transplantation for patients with mildly reduced renal function as defined based on creatinine clearance before transplantation.
Oshima K, Kanda Y, Nanya Y, Tanaka M, Nakaseko C, Yano S, Fujisawa S, Fujita H, Yokota A, Takahashi S, Kanamori H, Okamoto S; Kanto Study Group for Cell Therapy. Oshima K, et al. Among authors: tanaka m. Ann Hematol. 2013 Jan;92(2):255-60. doi: 10.1007/s00277-012-1584-1. Epub 2012 Oct 4. Ann Hematol. 2013. PMID: 23053182
Prospective multicenter study of single-unit cord blood transplantation with myeloablative conditioning for adult patients with high-risk hematologic malignancies.
Mori T, Tanaka M, Kobayashi T, Ohashi K, Fujisawa S, Yokota A, Fujita H, Nakaseko C, Sakura T, Nannya Y, Takahashi S, Kanamori H, Kanda Y, Sakamaki H, Okamoto S; Kanto Study Group for Cell Therapy. Mori T, et al. Among authors: tanaka m. Biol Blood Marrow Transplant. 2013 Mar;19(3):486-91. doi: 10.1016/j.bbmt.2012.12.007. Epub 2012 Dec 16. Biol Blood Marrow Transplant. 2013. PMID: 23253560 Free article. Clinical Trial.
Does the hematopoietic cell transplantation specific comorbidity index (HCT-CI) predict transplantation outcomes? A prospective multicenter validation study of the Kanto Study Group for Cell Therapy.
Nakaya A, Mori T, Tanaka M, Tomita N, Nakaseko C, Yano S, Fujisawa S, Sakamaki H, Aotsuka N, Yokota A, Kanda Y, Sakura T, Nanya Y, Saitoh T, Kanamori H, Takahashi S, Okamoto S. Nakaya A, et al. Among authors: tanaka m. Biol Blood Marrow Transplant. 2014 Oct;20(10):1553-9. doi: 10.1016/j.bbmt.2014.06.005. Epub 2014 Jul 15. Biol Blood Marrow Transplant. 2014. PMID: 25034961 Free article.
Comparison of cord blood transplantation with unrelated bone marrow transplantation in patients older than fifty years.
Tanaka M, Miyamura K, Terakura S, Imai K, Uchida N, Ago H, Sakura T, Eto T, Ohashi K, Fukuda T, Taniguchi S, Mori S, Nagamura-Inoue T, Atsuta Y, Okamoto S. Tanaka M, et al. Biol Blood Marrow Transplant. 2015 Mar;21(3):517-25. doi: 10.1016/j.bbmt.2014.11.685. Epub 2014 Dec 8. Biol Blood Marrow Transplant. 2015. PMID: 25498906 Free article. Clinical Trial.
Comparison of Outcomes of 8/8 and 7/8 Allele-Matched Unrelated Bone Marrow Transplantation and Single-Unit Cord Blood Transplantation in Adults with Acute Leukemia.
Terakura S, Atsuta Y, Tsukada N, Kobayashi T, Tanaka M, Kanda J, Najima Y, Fukuda T, Uchida N, Takahashi S, Nagamura-Inoue T, Morishima Y, Miyamura K; Japan Society for Hematopoietic Cell Transplantation. Terakura S, et al. Among authors: tanaka m. Biol Blood Marrow Transplant. 2016 Feb;22(2):330-338. doi: 10.1016/j.bbmt.2015.10.006. Epub 2015 Oct 22. Biol Blood Marrow Transplant. 2016. PMID: 26476205 Free article.
Impact of age on outcomes of allogeneic hematopoietic stem cell transplantation with reduced intensity conditioning in elderly patients with acute myeloid leukemia.
Aoki J, Kanamori H, Tanaka M, Yamasaki S, Fukuda T, Ogawa H, Iwato K, Ohashi K, Okumura H, Onizuka M, Maesako Y, Teshima T, Kobayashi N, Morishima Y, Hirokawa M, Atsuta Y, Yano S, Takami A. Aoki J, et al. Among authors: tanaka m. Am J Hematol. 2016 Mar;91(3):302-7. doi: 10.1002/ajh.24270. Epub 2016 Jan 11. Am J Hematol. 2016. PMID: 26663096 Free article.
Cytogenetic risk stratification may predict allogeneic hematopoietic stem cell transplantation outcomes for chronic myelomonocytic leukemia.
Motohashi K, Fujisawa S, Doki N, Kobayashi T, Mori T, Usuki K, Tanaka M, Fujiwara S, Kako S, Aoyama Y, Onoda M, Yano S, Gotoh M, Kanamori H, Takahashi S, Okamoto S; Kanto Study Group for Cell Therapy (KSGCT). Motohashi K, et al. Among authors: tanaka m. Leuk Lymphoma. 2018 Jun;59(6):1332-1337. doi: 10.1080/10428194.2017.1387913. Epub 2017 Oct 16. Leuk Lymphoma. 2018. PMID: 29032731
Deferasirox for the treatment of iron overload after allogeneic hematopoietic cell transplantation: multicenter phase I study (KSGCT1302).
Tachibana T, Kanda J, Machida S, Saito T, Tanaka M, Najima Y, Koyama S, Miyazaki T, Yamamoto E, Takeuchi M, Morita S, Kanda Y, Kanamori H, Okamoto S; Kanto Study Group for Cell Therapy (KSGCT). Tachibana T, et al. Among authors: tanaka m. Int J Hematol. 2018 May;107(5):578-585. doi: 10.1007/s12185-017-2396-9. Epub 2018 Jan 5. Int J Hematol. 2018. PMID: 29305770 Clinical Trial.
15,360 results
You have reached the last available page of results. Please see the User Guide for more information.